Physician profile
Lloyd P Leonards
NPI 1952644056
$1,113.63
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $582 · 2021: $287 · 2023: $22.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $22.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $22.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $269.73 | 2019-2020 | |
| Alkermes, INC. | $177.92 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $141.48 | 2019-2020 | |
| Lilly USA, LLC | $96.92 | 2020-2023 | Jardiance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $90.43 | 2020-2021 | |
| Mdd US Operations, LLC | $84.47 | 2019 | |
| Indivior INC. | $73.58 | 2019-2021 | |
| Abbvie INC. | $70.89 | 2021 | |
| Zyla Life Sciences, INC. | $36.01 | 2020 | |
| Gilead Sciences, INC. | $27.37 | 2020-2021 | |
| Amgen INC. | $19.57 | 2021 | |
| Sun Pharmaceutical Industries INC. | $13.49 | 2021 | |
| Sk Life Science, INC. | $11.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lloyd Leonards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.